The possibility of epigenetic transmission of defects induced by teratogens

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 422, Issue 2, 1998, Pages 203-205

  Holliday, Robin ^a  

^a NONE   (Australia)

Author keywords

Development; DNA methylation; Epigenetics; Teratogen; Thalidomide

Indexed keywords

TERATOGENIC AGENT; THALIDOMIDE;

ARTICLE; CARCINOGENESIS; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; EMBRYO; FEMALE; HUMANS; LIMB DEFORMITIES, CONGENITAL; MICE; MUTATION; PREGNANCY; TERATOGENS; THALIDOMIDE;

EID: 0032481013     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00219-X     Document Type: Article

References (21)

1. R. Holliday, DNA methylation in eukaryotes: 20 years on, in: V.E.A. Russo, R.A. Martienssen, A.D. Riggs (Eds.), Epigenetic Mechanisms of Gene Regulation, Cold Spring Harbor Laboratory Press, New York, 1996, pp. 5-27.
2. V.E.A. Russo, R.A. Martienssen, A.D. Riggs (Eds.), Epigenetic Mechanisms of Gene Regulation, Cold Spring Harbor Laboratory Press, New York, 1996.
3. Saluz H.P., Feavers I.M., Jiricny J., Jost J.P. Genomic sequencing and in vivo foot-printing of an expression specific hypersensitive site of avian vitellogenin II promoter reveals demethylation of a mCpG and a change in specific interaction of proteins with DNA. Proc. Natl. Adac. Sci. USA. 85:1988;6697-6700.
4. Holliday R. Inheritance of epigenetic defects. Science. 238:1987;163-170.
5. Silva A.J., White R. Inheritance of allelic blue prints for methylation patterns. Cell. 54:1988;1-11.
6. E. Jablonka, M. Lamb, Epigenetic Inheritance and Evolution. Oxford University Press, Oxford, 1995.
7. McBride W.G. Teratogenic action of drugs. Medical Journal of Australia. 2:1963;659-6698.
8. Lenz W. A short history of thalidomide embryopathy. Teratology. 38:1988;203-215.
9. McBride W.G. Thalidomide may be a mutagen. Brit. Medical Journal. 308:1994;1635-1636.
10. Read A.P. Thalidomide may be a mutagen: comment. Brit. Medical Journal. 308:1994;1636.
11. Smithells R.W. Thalidomide may be a mutagen. Brit. Medical Journal. 309:1994;477.
12. Kida M. Thalidomide may not be a mutagen. Brit. Medical Journal. 309:1994;741.
13. Ashby J. Thalidomide is not a mutagen. Nature. 389:1997;118.
14. W.G. McBride, pers. comm.
15. Nomura T. Parental exposure to X-rays and chemicals induces tumours and anomalies in mice. Nature. 296:1982;275-279.
16. Lord B.I., Woolford L.B., Wang L., Stones V.A., McDonald D., Lorimore S.A., Papworth D., Wright E.G., Scott D. Tumour induction by methyl-nitroso-urea following pre-conceptional paternal contamination with plutonium-239. Brit. J. Cancer. 78:1998;301-311.
17. Ashby J., Tinwell H., Callander R.D., Kimber I., Clau P., Galloway S.M., Hill R.B., Greenwood S.K., Gaulden M.E., Ferguson M.J., Vogel E., Nivard M., Parry J.M., Williamson J. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints. Mutation Res. 396:1997;45-64.
18. Huang P.H.T., McBride W.G. Thalidomide induced alteration in secondary structure of rat embryonic DNA in vivo. Teratog. Carcinog. Mutag. 10:1990;281-294.
19. 14C ] thalidomide with rat embryonic DNA in vivo Teratog. Carcinog. Mutag. 17:1997;1-5.
20. Neubert R., Neubert D. Peculiarities and possible mode of action of thalidomide. Handbook Exp. Pharmacol. 124(11):1997;41-119.
21. Neubert D. Never-ending tales of the mode of the teratogenic action of thalidomide. Teratog. Carcinog. Mutag. 17:1997;i-ii.